High Neutrophil/Lymphocyte Ratios in Symptomatic Pediatric COVID-19 Patients
| Autor: | Mehmet Ali Narsat, Emrah Cigri, Busra Calisir, Zubeyde Dincer, Eren Yildiz |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
medicine.medical_specialty Adolescent Turkey Cross-sectional study Neutrophils Asymptomatic Pediatrics Procalcitonin Cerebral palsy Internal medicine Diabetes mellitus medicine Humans Lymphocytes Child Retrospective Studies business.industry SARS-CoV-2 COVID-19 Retrospective cohort study General Medicine medicine.disease Pneumonia Cross-Sectional Studies Anorexia nervosa (differential diagnoses) Child Preschool Female medicine.symptom business |
| Zdroj: | Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. 31(7) |
| ISSN: | 1681-7168 |
| Popis: | OBJECTIVE: To investigate the symptoms and laboratory results of children hospitalised with the diagnosis of COVID-19, aiming to reveal the characteristics of symptomatic cases. STUDY DESIGN: A descriptive cross-sectional study. PLACE AND DURATION OF STUDY: Department of Pediatrics, Kastamonu Training and Research Hospital, Kastamonu, Turkey from March to December 2020. METHODOLOGY: Seventy-nine children, hospitalised with the diagnosis of COVID-19, were included in the study and were divided into two groups as symptomatic and asymptomatic. The demographic data, laboratory results and clinics of the patients of the two groups were compared. RESULTS: The mean age of participants was 10.43 ± 5.91 (0-17) years, and 57% (n=45) of them were girls. Five patients in the symptomatic group had comorbidities (2 allergic asthma, cerebral palsy, type-1 diabetes mellitus and anorexia nervosa). The most common symptom was fever (36.7%, n=29). It was noteworthy that everyone with an NLR >3.13 (high-NLR) was symptomatic. Significantly more patients in the high-NLR group were symptomatic compared with the low-NLR group (p=0.005). On the other hand, symptomatic children had significantly higher levels of C-reactive protein (2.8 (IQR: 1.2-10.0) mg/L vs. 1.4 (IQR: 0.4-2.0) mg/L, p=0.011); and procalcitonin (0.05 (IQR: 0.02-0.10) ng/mL vs. 0.01 (IQR: 0.00-0.03) ng/mL, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|